A Joint Specialist’s 40-Year Insight: Weight, Muscle, and Posture Are the Three Pillars of Joint Health
Luxury cars, designer watches, and high-end fashion—to the truly wealthy, these are no longer the ultimate status symbols.
Search results for "cell therapy"
Idience Targeted Cancer Drug Candidate ‘Venadaparib’ Granted FDA Fast Track Designation
Idience, a novel anticancer drug developer under the Ildong Pharmaceutical Group, announced on the 18th that its targeted cancer drug candidate...
The 'Frontline' Experience on an Uncharted Planet
"Why are you here, doctor?""I wonder? I don't know either," I replied, smiling awkwardly as I took a sip of the drink...
Datroway Approved: New Targeted Therapy Offers Hope for Metastatic Breast Cancer
A new therapeutic horizon has arrived for patients battling metastatic breast cancer that has progressed despite...
Rznomics to Present Oral Report on Breakthrough Anti-Cancer Gene Therapy at AACR
Rznomics, a biotechnology company specializing in RNA-based gene therapies, announced on March 5 that it has been...
Busan On Hospital to Introduce Proton Therapy: Expanding to Vietnam and Russia
Busan On Hospital has announced a bold new vision on the occasion of its 16th anniversary, aiming to establish a global...
VigenCell "Primary Endpoint Achieved"... Will a Domestic NK/T Lymphoma New Drug Be Born?
VigenCell has announced plans to apply for conditional approval within the year as it successfully completed...
Onconic’s ‘Nesuparib’ Secures U.S. FDA Orphan Drug Designation for Small Cell Lung Cancer
Onconic Therapeutics announced on the 24th that its novel anti-cancer candidate, 'Nesuparib', has been designated as an...
Breaking the Resistance: New Cause for Glioblastoma Recurrence Identified
Glioblastoma is widely regarded as the most aggressive and devastating form of brain cancer.
K-Bio Targets Global Expansion: HK inno.N and HLB Seek FDA Approval
South Korean pharmaceutical and biotech companies are aggressively pursuing product approvals and clinical trials with...